Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 14, Pages 4957
Publisher
MDPI AG
Online
2020-07-14
DOI
10.3390/ijms21144957
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Albendazole suppresses cell proliferation and migration and induces apoptosis in human pancreatic cancer cells
- (2020) Haifeng Chen et al. ANTI-CANCER DRUGS
- Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells
- (2020) Antonio Di Grazia et al. Cancers
- Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy
- (2019) Jiangbo Wang et al. BIOCHEMICAL JOURNAL
- Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
- (2019) Patrycja Nowak-Sliwinska et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Anti-parasitic Drug Ivermectin Exhibits Potent Anticancer Activity Against Gemcitabine-resistant Cholangiocarcinoma In Vitro
- (2019) KITTI INTUYOD et al. ANTICANCER RESEARCH
- Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities
- (2019) Eduardo José Barbosa et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide
- (2019) Federica Laudisi et al. CANCER LETTERS
- Rafoxanide promotes apoptosis and autophagy of gastric cancer cells by suppressing PI3K /Akt/mTOR pathway
- (2019) Jia-Zhou Liu et al. EXPERIMENTAL CELL RESEARCH
- Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain
- (2019) P. Ripani et al. ONCOGENE
- Niclosamide inhibits the cell proliferation and enhances the responsiveness of esophageal cancer cells to chemotherapeutic agents
- (2019) Ming‑Cheng Lee et al. ONCOLOGY REPORTS
- Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma
- (2019) Nancy S. Younis et al. Scientific Reports
- Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress
- (2018) Jiaqiao Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- YAP/TAZ initiates gastric tumorigenesis via upregulation of MYC
- (2018) Wonyoung Choi et al. CANCER RESEARCH
- Niclosamide: Beyond an antihelminthic drug
- (2018) Wei Chen et al. CELLULAR SIGNALLING
- Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy
- (2018) Dehong Chen et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer
- (2018) Amer Alasadi et al. Cell Death & Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway
- (2018) Ping Zhang et al. CELL PROLIFERATION
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- The novel role of pyrvinium in cancer therapy
- (2017) Amir A. Momtazi-borojeni et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer
- (2017) Yi Qu et al. Nature Chemical Biology
- The high price of anticancer drugs: origins, implications, barriers, solutions
- (2017) Vinay Prasad et al. Nature Reviews Clinical Oncology
- Drug repurposing in cancer
- (2017) Linda Sleire et al. PHARMACOLOGICAL RESEARCH
- Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer
- (2017) Sho Nambara et al. Oncotarget
- Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
- (2017) J. Javier Hernandez et al. Frontiers in Oncology
- Inhibition of CUG-binding protein 1 and activation of caspases are critically involved in piperazine derivative BK10007S induced apoptosis in hepatocellular carcinoma cells
- (2017) Ju-Ha Kim et al. PLoS One
- The Effect of Flubendazole on Adhesion and Migration in SW480 and SW620 Colon Cancer Cells
- (2017) Veronika Hanušová et al. Anti-Cancer Agents in Medicinal Chemistry
- Closantel Suppresses Angiogenesis and Cancer Growth in Zebrafish Models
- (2016) Xiao-Yu Zhu et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Pyrvinium selectively induces apoptosis of lymphoma cells through impairing mitochondrial functions and JAK2/STAT5
- (2016) Meifang Xiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cells
- (2016) Shunyan Weng et al. BMC GASTROENTEROLOGY
- Key cost drivers of pharmaceutical clinical trials in the United States
- (2016) Aylin Sertkaya et al. Clinical Trials
- Flubendazole induces mitotic catastrophe and senescence in colon cancer cellsin vitro
- (2016) Věra Králová et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway
- (2016) Malte B. Monin et al. JOURNAL OF SURGICAL RESEARCH
- Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
- (2016) Tara Williamson et al. Oncotarget
- Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile
- (2016) Major Gooyit et al. Scientific Reports
- Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay
- (2016) Yisu Li et al. Scientific Reports
- Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case–control study
- (2015) Supot Kamsa-ard et al. BMC CANCER
- Potential Anti-cancer Drugs Commonly Used for Other Indications
- (2015) Veronika Hanusova et al. CURRENT CANCER DRUG TARGETS
- Molecular Subtyping of Colorectal Cancer: Time to Explore Both Intertumoral and Intratumoral Heterogeneity to Evaluate Patient Outcome
- (2015) Eric R. Fearon et al. GASTROENTEROLOGY
- Protein localization vector propagation: a method for improving the accuracy of drug repositioning
- (2015) Yunku Yeu et al. Molecular BioSystems
- Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer
- (2015) W. Senkowski et al. MOLECULAR CANCER THERAPEUTICS
- Drug repurposing in oncology—patient and health systems opportunities
- (2015) Francesco Bertolini et al. Nature Reviews Clinical Oncology
- The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model
- (2015) Laine Celestino Pinto et al. TOXICOLOGY IN VITRO
- Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration
- (2015) Wei Xiang et al. Oncotarget
- Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
- (2015) Rebecca Lamb et al. Oncotarget
- Pharmacologic resistance in colorectal cancer: a review
- (2015) William A. Hammond et al. Therapeutic Advances in Medical Oncology
- Nitazoxanide: A first-in-class broad-spectrum antiviral agent
- (2014) Jean-François Rossignol ANTIVIRAL RESEARCH
- The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer
- (2014) A. Melotti et al. EMBO Molecular Medicine
- The impact of pyrvinium pamoate on colon cancer cell viability
- (2014) Armin Wiegering et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth
- (2014) V De Simone et al. ONCOGENE
- Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
- (2014) Bin Li et al. PLoS One
- Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer
- (2013) Peter Nygren et al. ACTA ONCOLOGICA
- Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) R. Labianca et al. ANNALS OF ONCOLOGY
- Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines
- (2013) Věra Králová et al. ANTI-CANCER DRUGS
- Novel Piperazine-based Compounds Inhibit Microtubule Dynamics and Sensitize Colon Cancer Cells to Tumor Necrosis Factor-induced Apoptosis
- (2013) Avijeet Chopra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
- (2013) Peter Nygren et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Praziquantel Synergistically Enhances Paclitaxel Efficacy to Inhibit Cancer Cell Growth
- (2012) Zhen Hua Wu et al. PLoS One
- Levamisole receptors: a second awakening
- (2012) Richard J. Martin et al. TRENDS IN PARASITOLOGY
- Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations
- (2011) T. Osada et al. CANCER RESEARCH
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
- (2010) Curtis A Thorne et al. Nature Chemical Biology
- Rapidly rising clinical trial costs worry researchers
- (2009) R. Collier CANADIAN MEDICAL ASSOCIATION JOURNAL
- Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells
- (2008) Joachim Müller et al. INTERNATIONAL JOURNAL OF CANCER
- Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy
- (2008) De-Hua Yu et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More